Tenet Clinical Research Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 295.77%
(FY 2021)
- Profit 1157.28%
(FY 2021)
- Ebitda 1157.28%
(FY 2021)
- Net Worth 101.89%
(FY 2021)
- Total Assets 491.31%
(FY 2021)
About Tenet Clinical Research
The Corporate was formerly known as Ethical Education And Energy Solutions. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Devineni Suresh and Devineni Lakshmi serve as directors at the Company.
- CIN/LLPIN
U73100TG2010NPL071786
- Company No.
071786
- Company Classification
Private Not For Profit Company
- Incorporation Date
21 Dec 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Tenet Clinical Research?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devineni Suresh  | Director | 21-Dec-2010 | Current |
| Devineni Lakshmi | Director | 21-Dec-2010 | Current |
Financial Performance and Corporate Structure Insights of Tenet Clinical Research.
Tenet Clinical Research, for the financial year ended 2021, experienced significant growth in revenue, with a 295.77% increase. The company also saw a substantial improvement in profitability, with a 1157.28% increase in profit. The company's net worth Soared by an impressive increase of 101.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tenet Clinical Research?
In 2021, Tenet Clinical Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Krishna Godavari Coastal Energy Private LimitedActive 15 years 1 monthDevineni Lakshmi is a mutual person
Meenakshi North East Power Private LimitedActive 14 years 7 monthsDevineni Suresh is a mutual person
- Meenakshi Arunachal Power Private LimitedActive 14 years 4 months
Devineni Suresh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tenet Clinical Research?
Unlock and access historical data on people associated with Tenet Clinical Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tenet Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tenet Clinical Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
